Management Team
An experienced team
with global competitiveness
Dae-Won Kim, Ph.D.
Founder, Chief Executive Officer
- Professor, Yonsei University, Dept. Biochemistry
- Postdoc, Harvard Medical School
- PhD, Tufts Medical School
- BS, MS, Yonsei University
- Korean Society of Gene and Cell Therapy
- - President (2023-2024) / Board Member (2023-Present)
- Korean Society of Cartilage and Osteoarthritis
- - President (2025) / Vice President (2024) / Board Member (2017-Present)
- Regenerative Medicine Acceleration Foundation
- - Board Member (2023-2024)
- Osong Medical Innovation Foundation
- - Board Member (2025-2028)
- [Ministry of Health and Welfare] Advanced Regenerative Medicine and Advanced Biological Products Specialized Committee
- - Committee Member (2022-2023)
- [Ministry of Health and Welfare] Central Pharmaceutical Affairs Council
- - Committee Member (2024-2026)
- [Ministry of Science and ICT] Advanced Biotechnology Coordination Committee
- - Committee Member (2023-2027)
- [Office for Government Policy Coordination] National Industry-Academia-Research Cooperation Committee
- - Committee Member (2023-2025)
Young-Na Yum Ph.D.
Executive Vice President,
Chief Clinical Development Officer
- Deputy Director, NITR/KFDA Korea
- Postdoc, The Burnham Institute
- Deputy Director, NIFDS/MFDS Korea
- BS, MS, PhD, Yonsei University
Gwang-Lark Park
Vice President, CFO
Management Department
- CEO, CURACLE Co., Ltd.
- Vice president, Cell2In Inc.
- Venture incubating and management Consulting
- B.A. in business administration, Seoul National University
Daegun Kim Ph.D.
Executive Vice President, Chief Manufacturing Officer
- Director of R&D Planning, Hugel
- Technologies manager, Kimberly-Clark Innovation Center Asia
- Postdoc, Harvard Medical School
- PhD, Seoul National University
Heui-Young Ryu D.Sc.
Executive Vice President, Chief Quality Officer
- Deputy Director, MFDS Korea
- MS, DSc, Boston University, School of Public Health
- MS, Seoul National University, Graduate School of Public Health
Minsun Park Ph.D.
Vice President, Research & Development Department
- Research Assistant Professor, Yonsei University, College of Medicine Institute of Behavioral Science in Medicine
- PhD, Yonsei University
Wonsik Shin Ph.D.
Vice President, Process Development Department
- Research Professor, Institute of Life Science and Biotechnology, Yonsei University
- Ph.D., Yonsei University
Sungwoo Hong
Business Development Department
- Team Leader, Handok Corporate Development
- Senior Investment Manager, LB Investment
- Professional, Amorepacific Corp. Future Growth Team
Barbara Thorne Ph.D.
Senior Director, CMC
- Celladon Corporation
- Targeted Genetics Corp.
- Xcyte Therapies
Alison Heald M.D.
Senior Director, Clinical Development
- University of Washington Medical Center
- Targeted Genetics Corp.
- Sarepta Therapeutics